Sign In
Free Newsletter
Rockefeller announces Summit Medical as newest tenant at Florham Park complex
Summit Medical Group will occupy the newest building at The Green at Florham Park, the Rockefeller Group's sprawling master-planned site that last year welcomed BASF's new North American headquarters, the developer announced today.
Monroe provides 35M loan to fuel Accutest Labs’ growth
Chicago-based Monroe Capital LLC announced on Tuesday it will provide a $35 million loan to Accutest Laboratories, in the Dayton section of South Brunswick, to further its growth. The loan, a unitranche credit facility, will be provided through Bolder Capital LLC, according to the announcement.
Actavis, Medicines360 announce partnership on birth control
Parsippany-based pharmaceutical company Actavis Inc. and California-based Medicines360, a nonprofit pharmaceutical company, announced Tuesday a partnership to support Medicines360’s mission to reduce cost as a barrier to accessing birth control.
Nautilus, Vertical announce promotion agreement
Bedminster-based specialty pharmaceutical company Nautilus Neurosciences Inc. announced Tuesday it has entered into a partnership with Sayreville-based Vertical Pharmaceuticals to co-promote a muscle relaxer to Nautilus' customers.
Cooper announces cancer partnership with leading treatment, research facility
Gov. Chris Christie was expected to announce this morning a partnership between Cooper University Health Care and Houston-based MD Anderson Cancer Center, under which the pair would open their first jointly operated cancer center in October on the campus of the Camden hospital.
Actavis confirms generic Diprivan patent challenge
Parsippany-based Actavis Inc. on Friday said it filed an abbreviated new-drug application with the U.S. Food and Drug Administration seeking approval to market a generic version of Fresenius Kabi's Diprivan, an intravenously administered sedative and anesthetic.
Out-of-state companies see opportunity in N.J. Medicaid expansion
When the Affordable Care Act bring another 300,000 New Jerseyans into the Medicaid program, it will create an opportunity for the four managed-care companies doing business here. But they won't be alone — four additional health care companies have announced plans to enter the state's Medicaid market next year to compete for nearly 1.6...
To put revenue in rare form, a focus on uncommon disease
CEO Francois Nader envisions NPS Pharmaceuticals Inc. becoming a billion-dollar revenue company by the end of the decade.
Life sciences, tech companies say regulatory burdens are chief concern
Both life science and technology companies industries say regulatory burdens represent their top challenge, according to a new report from consulting firm BDO USA LLP.
N.J. Nursing Initiative names program director
Aline Holmes, senior vice president of clinical affairs for the Princeton-based New Jersey Hospital Association, has been selected by the New Jersey Nursing Initiative, which has offices in Princeton and Trenton, to serve as one of two program directors tasked with addressing the state's nurse faculty shortage.
Cooper names senior vice president
Camden-based Cooper University Health Care announced Thursday that Barbara H. Smith has been appointed senior vice president of ambulatory operations.
Push for personalized medicine coming from high health costs, executive says
Pressure to contain spiraling health care costs is creating greater demand for personalized and innovative medicine, a venture capitalist told a gathering of biotechnology representatives Thursday.
